Based on biochemical knowledge, a metabolic network was formed from metabolites that were screened as differential metabolites in AKT/c-Met-induced HCC and CuB therapy, and this network was displayed using Cytoscape 3.8.2 software. The gene discussed is AKT1; the disease is hepatocellular carcinoma.